Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV Coinfection
NCT02294136 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 85
Last updated 2017-05-02
Summary
End-stage liver disease, predominantly due to hepatitis C virus (HCV) infection, is one of the leading causes of death in person living with HIV infection. While HCV is curable and recent advances in treatment have increased the rates of cure, few patients with HIV and HCV are being treated to cure HCV. Based on formative research, the investigators developed the "Psychosocial Readiness Evaluation and Preparation for hepatitis C treatment (PREP-C)". PREP-C is a clinical interview that healthcare providers of diverse disciplines can be trained to administer. It provides an assessment of a client's psychosocial readiness to begin HCV treatment and identifies domains of functioning which require intervention to improve treatment readiness. PREP-C (www.prepC.org) is also a telemedicine resource for health care providers. Under this protocol, the existing PREP-C clinical interview (or assessment) is incorporated with a behavioral intervention. This study tests the integrated assessment-behavioral intervention to increase HCV treatment initiation among HIV-co-infected patients. The assessment-behavioral intervention under this protocol is conducted in two phases, an Intervention Development phase and a Pilot Randomized Clinical Trial (RCT) phase.
Findings from this vanguard study will inform the design parameters of a larger, more rigorous evaluation in an R01 application, if results are promising. The PREP-C web-based assessment and intervention package is designed to be scalable and can be disseminated through the live PrepC.org web site. The proposed study is innovative in that it seeks to develop the first web-based intervention for health care providers to use to increase HCV treatment initiation in HIV/HCV-co-infected persons. The study can have a major public health impact by providing needed structured resources for health care providers to increase rates of HCV treatment initiation in HIV/HCV-co-infected persons, thereby reducing mortality due to end-stage liver disease.
Conditions
- HIV
- Hepatitis C
- Co-Infection
Interventions
- BEHAVIORAL
-
Prep-C
PREP-C is a web-based structured clinical interview that healthcare providers of diverse disciplines can be trained to administer. It provides an assessment of a client's psychosocial readiness to begin HCV treatment and identifies domains of functioning which require tailored intervention to improve treatment readiness.
- BEHAVIORAL
-
Educational Control
Attention Control
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
collaborator NIH -
Icahn School of Medicine at Mount Sinai
lead OTHER
Principal Investigators
-
Jeffrey J Weiss, PhD · Icahn School of Medicine at Mount Sinai
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-12-31
- Primary Completion
- 2017-04-28
- Completion
- 2017-04-28
Countries
- United States
Study Locations
More Related Trials
-
Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV Therapy
NCT00747539 ·Status: COMPLETED
-
Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients
NCT03413696 ·Status: COMPLETED
-
Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)
NCT01448915 ·Status: COMPLETED
-
Transforming the Cascade Of Hepatitis C Care
NCT03226509 ·Status: COMPLETED
-
Patient-Centered Models of HCV Care for People Who Inject Drugs
NCT02824640 ·Status: COMPLETED ·Phase: NA
-
Evaluation of HepCure Toolkit to Improve Harvoni Adherence
NCT02740556 ·Status: COMPLETED ·Phase: NA
-
Nurse Case Management to Improve Hepatitis C Care in HIV Co-infection
NCT02707991 ·Status: COMPLETED ·Phase: NA
-
Accessible HCV Care Intervention for People Who Inject Illicit Drugs (PWID)
NCT03214679 ·Status: COMPLETED ·Phase: NA
-
HCV Treatment Initiation During Acute Psychiatric Admission
NCT04625322 ·Status: UNKNOWN ·Phase: PHASE4
-
Pilot Treatment as Prevention for HCV Among Persons Who Actively Inject Drugs
NCT02609893 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial to Reduce Hepatitis C Among Injection Drug Users - 1
NCT00218192 ·Status: COMPLETED ·Phase: PHASE3
-
Improving Hepatitis C Treatment in Injection Drug Users
NCT00148031 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Reduce Intravenous Exposures (STRIVE)
NCT00391482 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Antiviral Pharmacology and Adherence in Drug Users
NCT02573376 ·Status: COMPLETED ·Phase: NA
-
A Community-based, Behavioral Intervention to Improve Screening for Hepatitis C Among High-risk Young Adults in Wisconsin
NCT02474043 ·Status: COMPLETED ·Phase: NA
-
Counseling Hepatitis C Virus (HCV) Positive Patients for Cardiovascular Disease Risk Factors
NCT03402334 ·Status: COMPLETED ·Phase: NA
-
Effects of HIV and Hepatitis C Virus on the Brain
NCT00494936 ·Status: COMPLETED
-
Hepatitis C Self-Management
NCT00328042 ·Status: COMPLETED ·Phase: NA
-
Integrated Care for Patients With High Risk Substance Use and Psychiatric Disorder With Chronic Direct Acting Antiviral Treatment
NCT02648022 ·Status: COMPLETED ·Phase: NA
-
Tool to Improve Treatment Adherence and Outcomes at Grady Liver Clinic
NCT03831555 ·Status: COMPLETED ·Phase: NA
-
Re-engaging Patients With Hepatitis C Into Care
NCT04029246 ·Status: UNKNOWN ·Phase: NA
-
Adherence in Patients Receiving PegIntron/Rebetol for Hepatitis C in Conjunction With a Psychotherapy Support Program (Study P04252)
NCT00723892 ·Status: COMPLETED
-
Way to Cure HCV Adherence
NCT02472925 ·Status: COMPLETED ·Phase: NA
-
Overcoming Psychiatric Barriers to the Treatment of Hepatitis C
NCT00407732 ·Status: COMPLETED ·Phase: NA
-
Treatment of Hepatitis C in Psychiatric Patients
NCT00751426 ·Status: COMPLETED